Blood at 70: Its roots in the history of hematology and its birth

Blood

Volumn 126, Issue 24, 2015, Pages 2548-2560

  Coller, Barry S ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BLOOD CLOTTING; BLOOD TRANSFUSION; BONE MARROW; CLINICAL PRACTICE; CYTOLOGY; FIBRINOLYSIS; HEMATOLOGY; HEMATOPOIESIS; HEMOLYTIC ANEMIA; HISTORY OF MEDICINE; HUMAN; LEUKEMIA; LEUKOCYTE; LYMPHATIC SYSTEM; LYMPHOMA; MEDICAL SOCIETY; PRIORITY JOURNAL; PUBLICATION; RESEARCH; REVIEW; STEM CELL; THROMBOCYTE; WAR; ANIMAL; BIBLIOMETRICS; EUROPE; FUNCTIONS OF THE HEMIC, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEMS; HEMATOLOGIC DISEASE; HISTORY; MILITARY MEDICINE; PHYSIOLOGY; TRENDS; UNITED STATES;

ANIMALS; BIBLIOMETRICS; BLOOD PHYSIOLOGICAL PHENOMENA; BLOOD TRANSFUSION; EUROPE; HEMATOLOGIC DISEASES; HEMATOLOGY; HEMATOPOIESIS; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LEUKOCYTES; MILITARY MEDICINE; PERIODICALS AS TOPIC; UNITED STATES; WORLD WAR II;

EID: 84951304222     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-09-659581     Document Type: Review

References (152)

1. Jaffé ER, Kaushansky K. The American Society of Hematology: a success at age 50. Blood. 2008;111(1):11-15.
2. Ham TH. Narrative history of the American Society of Hematology through the Twentieth Annual Meeting in 1977. Washington, DC: Archives of the American Society of Hematology; 1978.
3. Lichtman MA, Spivak JL, Shattil SJ, Boxer LA, Henderson ES, eds. Hematology: Landmark Papers of the Twentieth Century. San Diego, CA: Academic Press; 2000.
4. Wintrobe MM. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980.
5. Dreyfus C. Some Milestones in the History of Hematology. New York, NY: Grune & Stratton; 1957.
6. Ebel E. The Quick Tests: The Life and Work of Dr. Armand J. Quick. Blacksburg, VA: Pochantas Press; 1995.
7. Karnad AB. Intrinsic Factors: William Bosworth Castle and the Development of Hematology and Clinical Investigation at Boston City Hospital. Boston, MA: The Francis A. Countway Library of Medicine; 1997.
8. Freirich EJ, Lemak NA. Milestones in Leukemia Research and Therapy. Baltimore, MD: The Johns Hopkins University Press; 1991.
9. Lichtman MA. Historical landmarks in the understanding of the lymphomas. In: Wiernik PH, Goldman JM, Dutcher JP, Kyle RA, eds. Neoplastic Diseases of the Blood. New York, NY: Springer; 2013:789-833.
10. Wintrobe MM. Hematology, the Blossoming of a Science: A Story of Inspiration and Effort. Philadelphia: Lea & Febiger; 1985.
11. Robb-Smith AH. Osler's influence on haematology. Blood Cells. 1981;7(3):513-536.
12. Coller BS. Historical perspective and future directions in platelet research. J Thromb Haemost. 2011;9(suppl 1):374-395.
13. Robb-Smith AH. Why the platelets were discovered. Br J Haematol. 1967;13(4):618-637.
14. Osler W. An account of certain organisms occurring in the liquor sanguinis. Proc R Soc Lond. 1874;22:391-398.
15. Ratnoff OD. Why do people bleed? In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980:601-657.
16. Wintrobe MM. Milestones on the path of progress. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980: 1-31.
17. Ehrlich P. Beitrage zur kenntnis der anilinfärbungen und ihrer verwendung in der mikroskopischen technik. Arch Mikr Anat. 1877; 13:263-277.
18. Cabot RC. A Guide to the Clinical Examination of the Blood for Diagnostic Purposes. New York, NY: William Wood and Company; 1898.
19. Spaet TH. Platelets: the blood dust. In: Wintrobe M, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980:549-571.
20. Wright JH. The origin and nature of blood plates. Boston Med Surg J. 1906;154:643-645.
21. Conley CL. Sickle-cell anemia: the first molecular disease. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980: 319-371.
22. Herrick JB. Peculiar elongated and sickleshaped red blood corpuscles in a case of severe anemia. Arch Intern Med (Chic). 1910;6(5): 517-521.
23. Weatherall DJ. Toward an understanding of the molecular biology of some common inherited anemias: the story or thalassemia. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980:373-414.
24. Cooley TB, Lee P. A series of cases of splenomegaly in children with anemia and peculiar bone changes. Trans Am Pediatr Soc. 1925;37:29-30.
25. Whipple GH, Bradford WL. Racial or familial anemia of children associated with fundamental disturbances of bone and pigment metabolism (Cooley-von Jaksch). Am J Dis Child. 1932; 44(2):336-365.
26. Arinkin MA. Die intravitale untersuchungsmethodik des knochenmarks. Folia Haematol (Frankf). 1929;38:233-240.
27. Duke WW. The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. JAMA. 1910;55(14):1185-1192.
28. Kaznelson P. Verschwinden den haemorrhagischen diathese bei einem fallen von essentieller thrombopenie (Frank) nach milz extirpation. Splenogene thrombolitische purpura. Wien Klin Wochenschr. 1916;29:1451-1454.
29. Downey H. Handbook of Hematology. New York, NY: Paul B. Hoeber, Inc.; 1938
30. Castle WB. The conqest of pernicious anemia. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980:283-317.
31. Minot GR, Murphy WP. Treatment of pernicious anemia by a special diet. JAMA. 1926;87(7): 470-476.
32. Castle WB. Observations on the etiologic relationship of achylia gastrica to pernicious anemia. Part 1. The effect of the administration to patients with pernicious anemia of the contents of the normal human stomach recovered after ingestion of beef muscle. Am J Med Sci. 1929;178(6):748-764.
33. Smith T. On changes in the red blood corpuscles in the pernicious anaemia of Texas cattle fever. Trans Assoc Am Physicians. 1891;6:263-278.
34. Vogel KM, McCurdy UF. Blood transfusion and regeneration in pernicious anemia. Arch Intern Med (Chic). 1913;12(6):707-722.
35. Krumbhaar EB. Reticulosis - increased percentage of reticulated erythrocytes in the peripheral blood. J Lab Clin Med. 1922;8:11-18.
36. Gulliver G, ed. The Works of William Hewson, F.R.S. London, England: The Sydenham Society; 1846.
37. Buchanan A. On the coagulation of the blood and other fibriniferous liquids. Lond Med Gaz. 1845;1:617-622.
38. Schmidt A. Zur Blutlehre. Leipzig, Germany: Vogel; 1892.
39. Morawitz P. Die Chemie der Blutgerinnung. Ergeb Physiol. 1905;4:307-422.
40. Quick AJ, Stanley-Brown M, Bancroft FW. A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci. 1935;190:501-511.
41. Patek AJ, Stetson RP. Hemophilia I. The abnormal coagulation of the blood and its relation to the blood platelets. J Clin Invest. 1936;15(5):531-542.
42. Patek AJ, Taylor FH. Hemophilia II. Some properties of a substance obtained from normal human plasma effective in accelerating the coagulation of hemophilic blood. J Clin Invest. 1937;16(1):113-124.
43. Dam H. Cholesterinstoffwechsel in hühnereirn und hühnchen. Biochem Z. 1929;215:475-492.
44. Butt HR, Snell AM. The use of vitamin K and bile in treatment of the hemorrhagic diathesis in cases of jaundice. Proc Mayo Clin. 1938;13: 74-80.
45. Dam H, Glavind J. Vitamin K in human pathology. Lancet. 1938;i:720-721.
46. Schofield FW. Damaged sweet clover: the cause of a new disease in cattle simulating hemorrhagic septicemia and black leg. J Am Vet Med Assoc. 1924;64:553-575.
47. Link KP. The discovery of dicumarol and its sequels. Circulation. 1959;19(1):97-107.
48. Link KP. A preparation from spoiled sweet clover [3,39-methylene-bis-(4-hydroxycoumarin)] which prolongs coagulation and prothrombin time of the blood: preliminary report of experimental and clinical studies. Proc Staff Meet Mayo Clin. 1941; 16:388-395.
49. Bingham J, Meyer OO, Pohle FJ. Studies on the hemorrhagic agent 3,39-methylenebis (4-hydroxycoumarin). I. Its effect on the prothrombin and coagulation time of the blood of dogs and humans. Am J Med Sci. 1941;202(4): 563-578.
50. Howell WH. Theories of blood coagulation. Physiol Rev. 1935;15:435-470.
51. McLean J. The discovery of heparin. Circulation. 1959;19(1):75-78.
52. Murray DWG, Jacques LB, Perrett TS, Best CH. Heparin and the thrombosis of veins following injury. Surgery. 1937;2:163-187.
53. Crafoord C. Preliminary report on post-operative treatment with heparin as a preventive of thrombosis. Acta Chir Scand. 1937;79:407-426.
54. Jorpes E. Heparin in the treatment of thrombosis. An account of its chemistry, physiology, and application in medicine. New York, NY: Oxford University Press; 1946.
55. Monkhouse FC, France ES, Seegers WH. Studies on the antithrombin and heparin cofactor activities of a fraction adsorbed from plasma by aluminum hydroxide. Circ Res. 1955;3(4): 397-402.
56. Dastre A. Fibrinolyse dans le sang. Arch Physiol Norm Pathol. 1893;5:661-663.
57. Tillett WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. J Exp Med. 1933;58(4): 485-502.
58. Kaplan MH. Nature and role of the lytic factor in hemolytic streptococcal fibrinolysis. Proc Soc Exp Biol Med. 1944;57:40-43.
59. Bizzozero J. Über einen neuen formbestandtheil des blutes und dessen rolle bei der thrombose und der blutgerinnung. Virchow's Arch Pathol Anat Physiol Klin Med. 1882;90:261-332.
60. Glanzmann E. Hereditäre hämmorhagische thrombasthenie. Ein beitrag zur pathologie der blutplättchen. Jahrbuch für Kinderheilkunde und Physische Erziehung. 1918;88:113-141.
61. Hayem G. L'Hématoblaste, Troisième Element du Sang. Paris, France: Presse Universitaires de France; 1923.
62. Chargaff E, Bancroft FW, Stanley-Brown M. Studies on the chemistry of blood coagulation. III. The chemical constituents of blood platelets and their role in blood clotting, with remarks on the activation of clotting by lipids. J Biol Chem. 1936;116:237-251.
63. Brinkhous KM. Clotting defect in hemophilia; deficiency in a plasma factor required for platelet utilization. Proc Soc Exp Biol Med. 1947;66(1): 117-120.
64. Hirose K. Relation between platelet count of human blood and the vasoconstrictor action after clotting. Arch Intern Med (Chic). 1918;21(5): 604-612.
65. Janeway TC, Richardson HB, Park EA. Experiments on the vasoconstrictor action of blood serum. Arch Intern Med (Chic). 1918;26: 565-603.
66. Rapport MM, Green AA, Page IH. Serum vasoconstrictor, serotonin; isolation and characterization. J Biol Chem. 1948;176(3): 1243-1251.
67. Zucker MB, Borrelli J. Quantity, assay and release of serotonin in human platelets. J Appl Physiol. 1955;7(4):425-431.
68. Von Willebrand EA. Hereditar pseudoemophili. Fin Lakaresallsk Handl. 1926;68:87-112.
69. Von Willebrand EA. Über hereditare pseudohämophilie. Acta Med Scand. 1931;76: 521-549.
70. Hewson W. Experimental Inquiries, Part II, A Description of the Lymphatic System in the Human Subject and Other Animals. London, England: J Johnson; 1774.
71. Reprinted in Gulliver G (ed). The Works of William Hewson, F.R.S. London, England: The Sydenham Society; 1846.
72. Craddock CG. Defenses of the body: the initiators of defense, the ready reserves, and the scavengers. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980:417-454.
73. Addison W. Experimental and practical researches on the structure and function of blood corpuscles; on inflammation and on the origin of nature of tubercles in the lungs. Trans Prov Med Surg Assoc. 1843;11:223-306.
74. Waller AV. Microscopic observations on the perforation of the capillaries by the corpuscles of the blood, and on the origin of mucus and pusglobules. Philos Mag. 1846;29(195):397-405.
75. Cohnheim JF. Über entzuendung und eiterung. Arch Pathol Anat Physiol Klin Med. 1867;40: 179-264.
76. Metchnikov I. Uber die beziehung der phagocyten zu milzbrandbacillen. Arch Pathol Anat. 1884;97:502-526.
77. Brown PK, Ophuls N. A fatal case of acute primary infectious pharyngitis with extreme leukopenia. Am Med. 1902;3:649-652.
78. Plum P. Agranulocytosis due to aminopryine; experimental and clinical study of 7 new cases. Lancet. 1935;i:15-18.
79. von Behring EA, Kitasato S. Über das zustandekommen der diphtherie-immunität und der tetanus immunität bei thieren. Dtsch Med Wochenschr. 1890;16:1113-1114.
80. Ehrlich P. On immunity with special reference to cell life. Proc R Soc Lond. 1900;66:424-448.
81. Ford WL. The lymphocyte - it's transformation from a frustrating enigma to a model of cellular function. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980: 457-508.
82. Harvey W. Exercitatio anatomica de motu cordis et sanguinis in animalibus. Frankfurt, Germany: William Fitzer; 1628.
83. Diamond LK. A history of blood transfusion. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980:659-688.
84. Blundell J. Observations on transfusion of blood by Dr. Blundell with a description of his gravitator. Lancet. 1828;ii:321-324.
85. Walker LG Jr. Carrel's direct transfusion of a five day old infant. Surg Gynecol Obstet. 1973; 137(3):494-496.
86. Crile G. The technique of direct transfusion of blood. Ann Surg. 1907;46(3):329-332.
87. Satterlee HS, Hooker RS. Transfusion of blood with special reference to the use of anticoagulants. JAMA. 1916;66:618-624.
88. Landsteiner K. Über agglutinationserscheinungen normalen menschlichen blutes. Berl Klin Wochenschr. 1901;14: 1132-1134.
89. Lewisohn R. Blood transfusion by the citrate method. Surg Gynecol Obstet. 1915;21:37-47.
90. Rous P, Turner JR. The preservation of living red blood cells in vitro: I. Methods of preservation. J Exp Med. 1916;23(2):219-237.
91. Rous P, Turner JR. The preservation of living red blood cells in vitro: II. The transfusion of kept cells. J Exp Med. 1916;23(2):239-248.
92. Lewisohn R. The development of the technique of blood transfusion since 1907. J Mt Sinai Hosp N Y. 1943;10:605-622.
93. Robertson OH. Transfusion with preserved red blood cells. BMJ. 1918;1(2999):691-695.
94. Landsteiner K, Levine P. A new agglutinable factor differentiating individual human bloods. Proc Soc Exp Biol Med. 1927;24:600-602.
95. Levine P, Stetson RE. An unusual case of intragroup agglutination. JAMA. 1939;113: 126-127.
96. Landsteiner K, Wiener AS. Studies on an agglutinogen (Rh) in human blood reacting with anti-rhesus sera and with human isoantibodies. J Exp Med. 1941;74(4):309-320.
97. Gunz FW. The dread leukemias and the lymphomas: their nature and their prospects. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 2015:511-546.
98. Virchow R. Weisses blut und milztumoren. Med Z. 1847;16:9-15.
99. Bennett JH. Two cases of disease and enlargement of the spleen in which death took place from the presence of purulent matter in the blood. Edinburgh Med Surg J. 1845;64:413-423.
100. Neumann E. Ein fall von leukämie mit erkrankung des knochenmarkes. Arch Heilk. 1870;11:1-14.
101. Lissauer H. Zwei fälle von leucaemie. Berl Klin Wochenschr. 1865;20:403-405.
102. Pusey WA. Report of cases treated with roentgen rays. JAMA. 1902;38:911-919.
103. Hodgkin T. On some morbid appearances of the absorbent glands and spleen. Med Chir Trans. 1832;17:68-114.
104. Wilks S. Cases of a peculiar enlargement of the lymphatic glands frequently associated with disease of the spleen. Guys Hosp Rep. 1856;2: 114-132.
105. Wilks S. Cases of enlargement of the lymphatic gland and spleen (or Hodgkin's disease). Guys Hosp Rep. 1865;11:56-67.
106. Greenfield WS. Specimens illustrative of the pathology of lymph-adenoma and leucocythemia. Trans Path Soc Lond. 1878;29: 272-304.
107. Sternberg C. Uber eine eigenartige unter dem bilde der psuedoleukamie verlaufende. Tuberculose des lymphatische apparates. Ztschr Heilk. 1898;19:21-90.
108. Reed DM. On the pathological changes in Hodgkin's disease, with special reference to its relation to tuberculosis. Johns Hopkins Hosp Rep. 1902;10:133-196.
109. Virchow R. Die Krankhaften Geschwülste. Berlin, Germany: A. Hirschwald; 1863.
110. Kundrat H. Ueber lympho-sarkomatosis. Wien Klin Wochenschr. 1893;6:211-213.
111. Dacie JV. The life span of the red blood cell and circumstances of its premature death. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980:211-255.
112. Donath J, Landsteiner K. Ueber paroxysmale hämoglobinurie. Munch Med Wochenschr. 1904; 51:1590-1593.
113. Hijmans van den Bergh AA. Ictère hémolytique avec crises hémoglobulinuriques. Rev Med. 1911;31:63-69.
114. Ashby W. The determination of the length of life of transfused blood corpuscles in man. J Exp Med. 1919;29(3):267-281.
115. Enneking J. Eine neue form intermittierender hämoglobinurie (haemoglobinuria paroxysmalis nocturna). Klin Wochenschr. 1928;7:2045-2047.
116. Ham TH. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobulinuria. Study of the mechanism of hemolysis in relation to acid-base equilibrium. N Engl J Med. 1937;217: 915-917.
117. Dacie JV. Paroxysmal nocturnal haemoglobinuria. Proc R Soc Med. 1963; 56:587-596.
118. Hawkins WB, Whipple GH. The life cycle of the red blood cell in the dog. Am J Physiol. 1938; 122:418-427.
119. Berlin NI, Waldmann TA, Weissman SM. Life span of red blood cell. Physiol Rev. 1959;39(3): 577-616.
120. Widal F, Abrami P, Brulé M. Les ictères d'origine hémolytique. Arch Mal Coeur Vaiss. 1908;1: 193-231.
121. Coombs RR, Mourant AE, Race RR. A new test for the detection of weak and incomplete Rh agglutinins. Br J Exp Pathol. 1945;26:255-266.
122. Weber EH, Kölliker A. Ueber die bedeutung der leber für die bildung der blutkörperchen der embryonen. Z Kardiol. 1846;4:160-167.
123. Lajtha LG. The common ancestral cell. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980:81-95.
124. Neumann E. Ueber die bedeutung des knochenmarkes fur die blutbildung. Zentralbl Med Wissensch. 1868;6:689.
125. Bizzozero G. Sulla funzione ematopoetica del midollo delle ossa. Zentralbl Med Wissensch. 1868;6:885.
126. Pappenheim A. Abstammung und entstehung der roten blutzelle. Virchow's Archiv Pathol Anat. 1898;151:89-158.
127. Pappenheim A. Von den gegenseitigen beziehungen der verschiedenen farblosen blutzellen zu einander. Virchow's Archiv Pathol Anat. 1898;159:40-85.
128. Naegeli O. Ueber rotes knochenmark und myeloblasten. Dtsch Med Wochenschr. 1900; 26(18):287-290.
129. Loutit JF, Mollison PL. Disodium-citrate-glucose mixture as a blood preservative. Br Med J. 1943; 2(4327):744-745.
130. Surgenor DM. Edwin J. Cohen and The Development of Protein Chemistry. Boston, MA: Center for Blood Research, Inc.; 2002.
131. Janeway CA. Plasma, the transport fluid for blood cells and humors. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York, NY: McGraw-Hill; 1980:573-599.
132. Heyl JT, Janeway CA. The use of human ablumin in military medicine. Part I. The theoretical and experimental basis for its use. U S Nav Med Bull. 1942;40:785-790.
133. Woodruff L, Gibson ST. The use of human ablumin in military medicine. Part II. The clinical evaluation of human albumin. U S Nav Med Bull. 1942;40:791-796.
134. Neuhouser LR, Lozner EL. The use of human ablumin in military medicine. Part III. The standard Army-Navy package of serum albumin human (concentrated). U S Nav Med Bull. 1942; 40:796-799.
135. Ebert RV, Stead EA, Gibson JG. Response of normal subjects to acute blood loss. Arch Intern Med (Chic). 1941;68:578-590.
136. Scatchard G, Batchelder AC, Brown A. Chemical, clinical, and immunological studies on the products of human plasma fractionation. VI. The osmotic pressure of plasma and of serum albumin. J Clin Invest. 1944;23(4):458-464.
137. Gibson T, Medawar PB. The fate of skin homografts in man. J Anat. 1943;77(pt 4): 299-310, 4.
138. Medawar PB. The behaviour and fate of skin autografts and skin homografts in rabbits: a report to the War Wounds Committee of the Medical Research Council. J Anat. 1944; 78(pt 5):176-199.
139. Cronkite EP, Jacobs GJ, Brecher G, Dillard G. The hemorrhagic phase of the acute radiation syndrome due to exposure of the whole body to penetrating ionizing radiation. Am J Roentgenol Radium Ther Nucl Med. 1952;67(5):796-804.
140. LeRoy GV. Hematology of atomic bomb casualties. AMA Arch Intern Med. 1950;86(5): 691-710.
141. Cronkite EP, Brecher G. The experimental therapy of the hemorrhagic phase of the radiation syndrome with platelet transfusions. Acta Radiol Suppl. 1954;116:376-380.
142. Jacobson LO. Hematologic recovery from radiation injury. Prog Hematol. 1956;1:311-317.
143. Jacobson LO. From atom to Eve. Perspect Biol Med. 1981;24(2):195-216.
144. Thomas ED. Bone marrow transplantation from the personal viewpoint. Int J Hematol. 2005; 81(2):89-93.
145. Jacobson LO, Goldwasser E, Fried W, Plzak LF. Studies on erythropoiesis. VII. The role of the kidney in the production of erythropoietin. Trans Assoc Am Physicians. 1957;70:305-317.
146. Widner WR, Storer JB, Lushbaugh CC. The use of x-ray and nitrogen mustard to determine the mitotic and intermitotic times in normal and malignant rat tissues. Cancer Res. 1951;11(11): 877-884.
147. Jacobson LO, Simmons EL. Comparison of the effects of isologous, homologous, and heterologous hematopoietic tissues on post-irradiation survival. Radiology. 1960;75: 6-10.
148. Groth CG, Brent LB, Calne RY, et al. Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles. World J Surg. 2000; 24(7):834-843.
149. Minot GR. Foreword to Blood, The Journal of Hematology. Blood. 1946;1(1):1-2.
150. Dameshek W. Editorial. Blood. 1946;1(1): 83-84.
151. News and Views. Blood. 1946;1(1):93-96.
152. Coller BS. The hematologist discoverer. The Hematologist: ASH News and Reports. 2013; 10(6):7,15.